CORRECTED: Skadden Guides Amicus Therapeutics' $847M Biopharm Buy
Skadden Arps Slate Meagher & Flom LLP is advising biotech company Amicus Therapeutics in its acquisition of Scioderm Inc., a company dedicated to finding therapies for rare diseases, which Amicus says...To view the full article, register now.
Already a subscriber? Click here to view full article